The FDA granted accelerated approval to Wegovy for patients with metabolic dysfunction-associated steatohepatitis.
Elaine Chen covers biotech, co-writes The Readout newsletter , and co-hosts STAT’s weekly biotech podcast, The Readout Loud . You can reach Elaine on Signal at elaineywchen.70.
Novo Nordisk’s obesity drug Wegovy was cleared by U.S. regulators on Frid... [739 chars]